In this video, Rafael Bejar, MD, PhD, University of California San Diego, San Diego, CA, briefly discusses the role of the innate immune system in the pathogenesis of myelodysplastic syndromes (MDS), and further highlights the importance of investigating novel ways to target the immune system to treat lower-risk patients. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.